State Street’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

State Street’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-81,773	Closed	-$3.53M	–	3766
2015 Q3	$3.53M	Sell	81,773 -30,673	-27%	-$1.29M	﹤0.01%	2699
2015 Q2	$4.75M	Buy	112,446 +10,086	+10%	+$425K	﹤0.01%	2645
2015 Q1	$3.97M	Buy	102,360 +2,340	+2%	+$90.1K	﹤0.01%	2697
2014 Q4	$3.37M	Buy	100,020 +4,441	+5%	+$157K	﹤0.01%	2781
2014 Q3	$3.35M	Sell	95,579 -56,202	-37%	-$1.93M	﹤0.01%	2763
2014 Q2	$4.99M	Sell	151,781 -3,781	-2%	-$129K	﹤0.01%	2592
2014 Q1	$5.74M	Sell	155,562 -27,336	-15%	-$1M	﹤0.01%	2499
2013 Q4	$7.02M	Sell	182,898 -10,414	-5%	-$329K	﹤0.01%	2378
2013 Q3	$5.29M	Sell	193,312 -17,353	-8%	-$411K	﹤0.01%	2498
2013 Q2	$4.42M	Buy	+210,665	New	+$4.11M	﹤0.01%	2534

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

State Street's WX Position: Q4 2015 in Review

State Street sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 81,773 shares — an estimated $3.53M sold.

State Street first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $7.02M in Q4 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

State Street reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
State Street sold 81,773 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $3.53M.
State Street first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
State Street's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $7.02M in Q4 2013.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on State Street's 13F filing for Q4 2015, filed 16 Feb 2016.